Ignite Creation Date:
2025-12-25 @ 12:37 AM
Ignite Modification Date:
2026-05-03 @ 8:14 PM
Study NCT ID:
NCT05932667
Status:
TERMINATED
Last Update Posted:
2023-12-21
First Post:
2023-06-13
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Milademetan and Fulvestrant in GATA3-mutant, ER+HER- Advanced or Metastatic Breast Cancer
Sponsor:
Institut Curie
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Advanced or Metastatic Breast Cancer | View |
Keywords: